Cervical cancer vaccine's impact 'underestimated'
By Tom Moberly, 14 July 2010
Vaccination could prevent up to 10% more cervical cancer cases than previously thought, UK research suggests.
A study found that 73-77% of cervical cancer cases were caused by either HPV type 16 or 18, both of which are prevented by the current vaccine used in the UK. Previous studies suggested that 70% of cases were caused by these types.
Writing in the British Journal of Cancer, the researchers said they believe that vaccination could reduce cervical cancer cases from 3,000 a year to under 700. The team included scientists from the Health Protection Agency, the University of Manchester and Manchester Royal Infirmary.
A substantial proportion of less serious cervical disease is also likely to be prevented by immunisation, the researchers said. This would mean that fewer women would need to be called back for further investigations and treatment following cervical screening.
View our Teenage Health resource centreFurther Reading
- Related Drug Categories
- Immunisation
- Related MIMS Tables
- Summary of Antibiotic Treatments in Adults
- Hormone Replacement Therapy (HRT)
Additional Information
Latest jobs Jobs web feed
- Full time GP partner - Isle of Man Laxey and Village Walk Health Centres Competitive, Isle of Man
- General Practitioner x 2 for MOD, RAF Leuchars, Fife MMP Competitive hourly rates offered, East Coast of Scotland
- Locum GPs Urgently South East and South West London- Earn up to £70 per hour! Merco £70/hour, South East and South West London
- Locum Consultant Dermatologists required, Nationwide up to £100/hour Merco Up to £100/hour, Nation-wide
- GP LOCUM SOMERSET AND DORSET Your World Recruitment EXCELLENT, DORSET AND SOMERSET
- Salaried GP Five Elms Medical Practice Negotiable, East London
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
